FDA's DTC Review Priorities Adapt to New PhRMA Principles

March 3, 2006

The FDA is making a major change to how it reviews DTC ads to account for an upsurge in the number of ads submitted since PhRMA’s new advertising principle went into effect Jan. 1, agency officials say.